Literature DB >> 10980618

Correct binding of viral X protein to UVDDB-p127 cellular protein is critical for efficient infection by hepatitis B viruses.

D Sitterlin1, F Bergametti, P Tiollais, B C Tennant, C Transy.   

Abstract

A fully effective treatment of chronic human hepatitis B virus (HBV) infection is still missing and HBV remains the first etiological agent of liver cancer. Although the viral regulatory X protein is essential for infection, its mode of action remains obscure, due the lack of an in vitro infection system. In the accompanying study, we showed the functional importance of interaction between X and the host protein UVDDB-p127, in the transactivation and apoptotic properties of the viral protein. Here, we addressed the biological role of X-UVDDB interaction in the infectious process using a genetic approach in the woodchuck virus closely related to HBV. We show that (i) mutations in X, which markedly affect UVDDB-binding, also abolished productive infection in woodchucks, (ii) in the few cases where mutant viruses led to infection, compensatory mutations had occurred in the X gene of the viral progeny, which restored correct UVDDB-binding. We conclude that efficient viral replication in vivo requires proper X-UVDDB interaction. The interaction may thus provide a novel therapeutic target for the treatment of hepatitis

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10980618     DOI: 10.1038/sj.onc.1203770

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  28 in total

Review 1.  The enigmatic X gene of hepatitis B virus.

Authors:  Michael J Bouchard; Robert J Schneider
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

2.  Nuclear HBx binds the HBV minichromosome and modifies the epigenetic regulation of cccDNA function.

Authors:  Laura Belloni; Teresa Pollicino; Francesca De Nicola; Francesca Guerrieri; Giuseppina Raffa; Maurizio Fanciulli; Giovanni Raimondo; Massimo Levrero
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-11       Impact factor: 11.205

3.  X-deficient woodchuck hepatitis virus mutants behave like attenuated viruses and induce protective immunity in vivo.

Authors:  Z Zhang; N Torii; Z Hu; J Jacob; T J Liang
Journal:  J Clin Invest       Date:  2001-11       Impact factor: 14.808

4.  Hepatitis B virus regulatory HBx protein binding to DDB1 is required but is not sufficient for maximal HBV replication.

Authors:  Amanda J Hodgson; Joseph M Hyser; Victor V Keasler; Yong Cang; Betty L Slagle
Journal:  Virology       Date:  2012-02-17       Impact factor: 3.616

5.  Hepatitis B virus X protein stimulates viral genome replication via a DDB1-dependent pathway distinct from that leading to cell death.

Authors:  Olivier Leupin; Séverine Bontron; Céline Schaeffer; Michel Strubin
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

6.  Altered DNA mutation spectrum in aflatoxin b1-treated transgenic mice that express the hepatitis B virus x protein.

Authors:  Charles R Madden; Milton J Finegold; Betty L Slagle
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

7.  The p127 subunit (DDB1) of the UV-DNA damage repair binding protein is essential for the targeted degradation of STAT1 by the V protein of the paramyxovirus simian virus 5.

Authors:  J Andrejeva; E Poole; D F Young; S Goodbourn; R E Randall
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

Review 8.  Role of HBx in hepatitis B virus persistence and its therapeutic implications.

Authors:  Betty L Slagle; Michael J Bouchard
Journal:  Curr Opin Virol       Date:  2018-02-20       Impact factor: 7.090

9.  A carboxy-terminal region of the hepatitis B virus X protein promotes DNA interaction of CREB and mimics the native protein for transactivation function.

Authors:  Honey Reddi; Ravinder Kumar; Swatantra Kumar Jain; Vijay Kumar
Journal:  Virus Genes       Date:  2003-05       Impact factor: 2.332

10.  Hepatitis B virus X protein and simian virus 5 V protein exhibit similar UV-DDB1 binding properties to mediate distinct activities.

Authors:  Olivier Leupin; Séverine Bontron; Michel Strubin
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.